Free Republic

Myocarditis Thrombosis Thrombocytopenia Cerebral Venous Thrombosis Vasculitis Guillain-Barré Syndrome Lymphadenopathy Anaphylaxis Myopericarditis Allergic Reactions Bell’s Palsy Axillary Adenopathy Pericarditis Acute Myelitis Perimyocarditis Intracerebral Haemorrhage Immune-Mediated Hepatitis Facial Nerve Palsy Neurological Symptoms Haemorrhage Immune-Mediated Disease Outbreaks Takotsubo cardiomyopathy Cardiac Rhabdomyolysis Thrombotic Thrombocytopenic Purpura Cardiovascular events Acute Hyperactive Encephalopathy Acute Kidney Injury Multiple Sclerosis Bleeding Episodes Cutaneous Adverse Effects Skin Reactions Vogt-Koyanagi-Harada syndrome Capillary Leak Syndrome Systemic Lupus Erythematosus Petechiae Purpura Annularis Telangiectodes Pulmonary Embolism Psoriasis Nephrotic Syndrome Bullous Drug Eruption Hemophagocytic Lymphohistiocytosis Pulmonary Embolism Blood Clots Thrombophilia iTTP episode Refractory Status Epilepticus Central Serous Retinopathy Cutaneous Reactions Prion Disease Pregnant Woman...

The results are in from the world’s largest study of ivermectin for COVID-19.Brazil has had over 23 million cases of COVID-19 since the pandemic began, with a 97% recovery rate.Researchers in Brazil found that regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization and mortality rates.The study was conducted in Itajaí, a port city in the state of Santa Catarina, between July and December 2020. Study authors include FLCCC physicians Dr. Flavio Cadegiani and Dr. Pierre Kory. Lead author Dr. Lucy Kerr was approached by the mayor of Itajaí, after the city began...

"Getting your Horse-Faced Horse-Paste Democrat Friends to swallow this truth bomb is going to be like feeding a pill to a cat. It is a peer-reviewed research study on Ivermectin from Brazil. We analyzed data from a prospective, observational study of the citywide COVID-19 prevention with ivermectin program, which was conducted between July 2020 and December 2020 in Itajaí, Brazil. The results: “…regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.” What does significant mean? According to the researchers, Ivermectin resulted in a 67% reduction in hospitalization and a 70%...

New Peer-Reviewed Study Shows Ivermectin ‘Significantly’ Reduces COVID Infections, Hospitalization, and Mortality RatesA newly released study from Brazil of over 150 thousand subjects found that regular prophylactic use of ivermectin “was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.”The largest ivermectin study to date was conducted in Itajaí, Brazil, between July 2020 and December 2020. It recently passed rigorous peer-review and was published this week, Dr. Pierre Kory noted on Twitter.Background: Ivermectin has demonstrated different mechanisms of action that potentially protect from both coronavirus disease 2019 (COVID-19) infection and COVID-19-related comorbidities. Based on the studies suggesting efficacy in...

Now up to 122 studies affirming the superiority of natural immunity, in contrast to one highly flawed, non-peer reviewed CDC study.122 Research Studies Affirm Naturally Acquired Immunity to Covid-19: Documented, Linked, and Quoted https://brownstone.org/articles/79-research-studies-affirm-naturally-acquired-immunity-to-covid-19-documented-linked-and-quoted/

PODCAST AUDIO: Alex Pierson talks with Dr. Byram Bridle, an Associate Professor on Viral Immunology at the University of Guelph (Canada) about new peer-reviewed studies that suggests there may be terrifying reasons side effects such as heart inflammation, VITT, and other serious issues may occur in those who have been vaccinated. SUMMARY OF PODCAST: The spike proteins of the SARS-CoV-2 virus alone can cause major damage to bodyFor example, the spike protein is almost entirely responsible for damage to the cardiovascular system in cases of SARS-CoV-2 infectionThe vaccines get cells in the body to manufacture the SARS-CoV-2 spike proteinScientist assumed...

The article concludes: "ivermectin should be globally and systematically deployed in the prevention and treatment of COVID-19." Unlike the vaccines, it is not an experimental drug and is known to be safe for all but a few with other conditions. I expect the corporate media will ignore as much as possible the findings of a peer-reviewed study just published in the American Journal of Therapeutics that concludes the readily-available, inexpensive (off-patent) drug ivermectin is effective in treating existing cases of Covid-19 and in preventing coming down with the illness. Unlike the experimental vaccines that we are being ceaselessly urged to...

A new study has found that the antimalarial drug hydroxychloroquine helped patients survive COVID-19 while in the hospital, countering the establishment media’s criticism of President Donald Trump when he suggested the same thing. The study was conducted by a team at Henry Ford Health System in Southeast Michigan and published in the International Journal of Infectious Diseases on Thursday. Researchers studied a group of 2,541 hospitalized patients and found mortality rates were substantially reduced when patients were treated with hydroxychloroquine. The study found that 13 percent of patients treated with just hydroxychloroquine died compared with 26.4 percent not treated with...

The anti-malarial drug hydroxychloroquine lowers the death rate of COVID-19 patients, U.S. researchers have said. Researchers conducted a retrospective analysis of over 2,500 patients hospitalized between March 10 and May 2 in the Henry Ford Health System in Michigan. Over 2,000 of the patients were given hydroxychloroquine or the anti-malarial with azithromycin, an antibiotic. The study found 13 percent of those who received hydroxychloroquine alone died compared to 26.4 percent who didn’t receive the drug. Hydroxychloroquine alone decreased the mortality hazard ratio by 66 percent and the anti-malarial with the antibiotic decreased the ratio by 71 percent, researchers said. The...

The large-scale analysis, conducted by Henry Ford Health System, was published Thursday in the peer-reviewed International Journal of Infectious Diseases. The study examined 2,541 patients who had been hospitalized in six hospitals between March 10 and May 2, 2020. More than twenty-six percent (26.4%) of patients who did not receive hydroxychloroquine died. But among those who received hydroxychloroquine, fewer than half that number — 13% — died. More than 90% of the patients received hydroxychloroquine within 48 hours of admission to the hospital. Scientists say giving the drug early during illness may be a key to success. The study’s authors...

DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System. In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a...

Phenomenon known as virus interference flagged in DOD study just before COVID-19 burst. Just a few short weeks before the COVID-19 pandemic burst into public view, a medical researcher published a study on military members who got the flu shot. At the time, it barely created a ripple but its findings are now likely to have a larger impact on the future policy debate over infectious respiratory viruses. The study published by Dr. Gregory Wolff in Science magazine was entitled, “Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season" and it addressed a...

Evidence is accumulating that quality control is a serious issue in academic publishing, which is the key to career advancement for scientists and other scholars. In an age when appeals to "peer reviewed" "settled science" have become standard operating procedure in efforts to impose radical increases in government control over our lives, corruption in the mechanisms for reviewing  scientific publications has very real consequences for all of us. Nature magazine tells us: Publishers withdraw more than 120 gibberish papers. Richard Van Noorden writes: The publishers Springer and IEEE are removing more than 120 papers from their subscription services after...

ClimateGate: Britain's Climate Research Unit now says it will release all its data. Does that include the data that have been shredded, deleted and denied publication? In a statement released Saturday by the University of East Anglia, where the CRU is located, it was announced that all unit data, including data that had been denied climate skeptics, would soon be released to prove this is much ado about nothing. Unimpressed by the news is David Holland of Northampton, a grandfather with a background in electrical engineering, who is seeking prosecution of the CRU scientists involved in suppressing and even destroying...